Good upside over next six to 12 months in Shasun Pharma: Avinnash Gorakssakar

In a chat with ET Now, Avinnash Gorakssakar, Founder Director, Moneyinvestments.in, shares his views on Shasun Pharma.

ET Now: What is it that you would be recommending if at all anything right now?

Avinnash Gorakssakar: We are recommending a stock called Shasun Pharma. Again it is not a short term call, it is a slightly medium term and we like the company because it is a niche player in the API as well as in the cram space. Valuations are extremely encouraging. In fact, stock trades at roughly about eight times FY13 numbers, so we are awaiting some more news flows tomorrow from the company’s conference call. I am quite positive that we could possibly see a good upside over the next six to 12 months.